Avalo Therapeutics Stock Market Value
| AVTX Stock | USD 10.13 0.48 4.97% |
| Symbol | Avalo |
Avalo Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avalo Therapeutics. If investors know Avalo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avalo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 94.42 | Revenue Per Share 0.396 | Quarterly Revenue Growth 0.055 | Return On Assets (0.31) | Return On Equity (0.43) |
The market value of Avalo Therapeutics is measured differently than its book value, which is the value of Avalo that is recorded on the company's balance sheet. Investors also form their own opinion of Avalo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Avalo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avalo Therapeutics' market value can be influenced by many factors that don't directly affect Avalo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avalo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avalo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avalo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Avalo Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Avalo Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Avalo Therapeutics.
| 12/05/2022 |
| 11/24/2024 |
If you would invest 0.00 in Avalo Therapeutics on December 5, 2022 and sell it all today you would earn a total of 0.00 from holding Avalo Therapeutics or generate 0.0% return on investment in Avalo Therapeutics over 720 days. Avalo Therapeutics is related to or competes with AnaptysBio, Arcellx, Structure Therapeutics, Aerovate Therapeutics, Alx Oncology, Anebulo Pharmaceuticals, and Acrivon Therapeutics,. Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted ... More
Avalo Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Avalo Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Avalo Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.67 | |||
| Information Ratio | 0.0551 | |||
| Maximum Drawdown | 32.25 | |||
| Value At Risk | (7.94) | |||
| Potential Upside | 12.18 |
Avalo Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Avalo Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Avalo Therapeutics' standard deviation. In reality, there are many statistical measures that can use Avalo Therapeutics historical prices to predict the future Avalo Therapeutics' volatility.| Risk Adjusted Performance | 0.0663 | |||
| Jensen Alpha | 0.5325 | |||
| Total Risk Alpha | (0.55) | |||
| Sortino Ratio | 0.0544 | |||
| Treynor Ratio | (1.20) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Avalo Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Avalo Therapeutics Backtested Returns
Avalo Therapeutics appears to be risky, given 3 months investment horizon. Avalo Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0357, which signifies that the company had a 0.0357% return per unit of standard deviation over the last 3 months. We have found thirty technical indicators for Avalo Therapeutics, which you can use to evaluate the volatility of the firm. Please makes use of Avalo Therapeutics' risk adjusted performance of 0.0663, and Mean Deviation of 4.88 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Avalo Therapeutics holds a performance score of 2. The firm shows a Beta (market volatility) of -0.4, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Avalo Therapeutics are expected to decrease at a much lower rate. During the bear market, Avalo Therapeutics is likely to outperform the market. Please check Avalo Therapeutics' value at risk, and the relationship between the standard deviation and kurtosis , to make a quick decision on whether Avalo Therapeutics' price patterns will revert.
Auto-correlation | -0.1 |
Very weak reverse predictability
Avalo Therapeutics has very weak reverse predictability. Overlapping area represents the amount of predictability between Avalo Therapeutics time series from 5th of December 2022 to 30th of November 2023 and 30th of November 2023 to 24th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Avalo Therapeutics price movement. The serial correlation of -0.1 indicates that less than 10.0% of current Avalo Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.1 | |
| Spearman Rank Test | -0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 12.71 |
Avalo Therapeutics lagged returns against current returns
Autocorrelation, which is Avalo Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Avalo Therapeutics' stock expected returns. We can calculate the autocorrelation of Avalo Therapeutics returns to help us make a trade decision. For example, suppose you find that Avalo Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Avalo Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Avalo Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Avalo Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Avalo Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Avalo Therapeutics Lagged Returns
When evaluating Avalo Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Avalo Therapeutics stock have on its future price. Avalo Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Avalo Therapeutics autocorrelation shows the relationship between Avalo Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Avalo Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Avalo Stock Analysis
When running Avalo Therapeutics' price analysis, check to measure Avalo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avalo Therapeutics is operating at the current time. Most of Avalo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Avalo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avalo Therapeutics' price. Additionally, you may evaluate how the addition of Avalo Therapeutics to your portfolios can decrease your overall portfolio volatility.